Novo Nordisk Pharmaceutical Industries LP (IFP facility)
Novo Nordisk's Clayton facility manufactures insulin, GLP-1 products and prefilled delivery devices for the treatment of diabetes.
Employment range in NC
Primary site activity
All company activities
Products on market
Insulin and GLP-1 products and delivery devices, growth hormone, hemostasis management, hormone replacement therapy